North Annette 4
4 · Turning Point Therapeutics, Inc. · Filed Feb 11, 2022
Insider Transaction Report
Form 4
North Annette
EVP, General Counsel & Secty.
Transactions
- Award
Common Stock
2022-02-09+16,283→ 27,979 total - Award
Stock Option (right to buy)
2022-02-09+58,600→ 58,600 totalExercise: $37.68Exp: 2032-02-08→ Common Stock (58,600 underlying) - Sale
Common Stock
2022-02-09$36.30/sh−669$24,285→ 11,696 total
Footnotes (3)
- [F1]Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to Reporting Person on February 8, 2021.
- [F2]Represents restricted stock unit award granted under the Issuer's 2019 Equity Plan.
- [F3]1/48th of the shares vest monthly following February 9, 2022.